These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules. Rezaei M; Khamaneh AM; Zarghami N; Vosoughi A; Hashemzadeh S BMC Cancer; 2019 Jul; 19(1):690. PubMed ID: 31307429 [TBL] [Abstract][Full Text] [Related]
44. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples. Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355 [TBL] [Abstract][Full Text] [Related]
45. A five-miRNA panel in plasma was identified for breast cancer diagnosis. Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692 [TBL] [Abstract][Full Text] [Related]
46. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test. Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801 [TBL] [Abstract][Full Text] [Related]
47. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
48. Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma. Chen X; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y Dis Markers; 2020; 2020():8880937. PubMed ID: 33224315 [TBL] [Abstract][Full Text] [Related]
49. Differential expression profiling of circulation microRNAs in PTC patients with non-131I and 131I-avid lungs metastases: a pilot study. Qiu ZL; Shen CT; Song HJ; Wei WJ; Luo QY Nucl Med Biol; 2015 May; 42(5):499-504. PubMed ID: 25682061 [TBL] [Abstract][Full Text] [Related]
50. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma. Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743 [TBL] [Abstract][Full Text] [Related]
51. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
52. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304 [TBL] [Abstract][Full Text] [Related]
53. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. Zhou X; Zhu W; Li H; Wen W; Cheng W; Wang F; Wu Y; Qi L; Fan Y; Chen Y; Ding Y; Xu J; Qian J; Huang Z; Wang T; Zhu D; Shu Y; Liu P Sci Rep; 2015 Jun; 5():11251. PubMed ID: 26059512 [TBL] [Abstract][Full Text] [Related]
54. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma. Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967 [TBL] [Abstract][Full Text] [Related]
55. Serum microRNA expression profiling revealing potential diagnostic biomarkers for lung adenocarcinoma. Shan X; Zhang L; Zhu DX; Zhou X; Zhang H; Liu QX; Tang JW; Wen W; Wang TS; Zhu W; Liu P Chin Med J (Engl); 2020 Nov; 133(21):2532-2542. PubMed ID: 32947363 [TBL] [Abstract][Full Text] [Related]
56. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
57. Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer. Rogucki M; Sidorkiewicz I; Niemira M; Dzięcioł JB; Buczyńska A; Adamska A; Siewko K; Kościuszko M; Maliszewska K; Wójcicka A; Supronik J; Szelachowska M; Reszeć J; Krętowski AJ; Popławska-Kita A Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681658 [TBL] [Abstract][Full Text] [Related]
58. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis. Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912 [TBL] [Abstract][Full Text] [Related]
59. Three plasma-based microRNAs as potent diagnostic biomarkers for endometrial cancer. Fan X; Cao M; Liu C; Zhang C; Li C; Cheng W; Zhang S; Zhang H; Zhu W Cancer Biomark; 2021; 31(2):127-138. PubMed ID: 33896823 [TBL] [Abstract][Full Text] [Related]
60. A meta-analysis of circulating microRNAs in the diagnosis of papillary thyroid carcinoma. Liu Y; Geng H; Liu X; Cao M; Zhang X PLoS One; 2021; 16(5):e0251676. PubMed ID: 34019567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]